Description

The Invasive Fungal Infection Cooperative Group (IFICG) of the European Organization for Research and Treatment of Cancer (EORTC) and the Mycoses Study Group of the National Institute of Allergy and Infectious Diseases (NIAID) have defined diagnostic categories associated with invasive opportunistic fungal infections in a patient with cancer or an hematopoietic stem cell transplant.


 

Determinations:

(1) confidence in diagnosis: proven vs probable vs possible vs not diagnosed

(2) organism: mold vs Candida species vs Cryptococcus vs dimorphic yeast

(3) syndrome: pulmonary vs sinonasal vs CNS vs fungemia vs disseminated

 

Proven deep tissue infection with mold - one or both of the following:

(1) microscopic examination demonstrating fungal form AND microscopic or imaging evidence of tissue injury

(2) positive culture from normally sterile site (not urine or mucuous membrane) AND clinical and/or radiologic findings consistent with infection

 

Proven deep tissue infection with yeast - one or more of the following:

(1) microscopic examination demonstrating fungal form AND microscopic or imaging evidence of tissue injury

(2) positive culture from normally sterile site (not urine, sinus or mucuous membrane) AND clinical and/or radiologic findings consistent with infection

(3) antigen for Cryptococcus in CSF AND clinical and/or radiologic findings consistent with infection AND no evidence of a false positive antigen test

 

Proven fungemia with mold – both of the following:

(1) positive blood culture

(2) compatible signs and symptoms

 

Proven fungemia with yeast – both of the following:

(1) positive blood culture

(2) compatible signs and symptoms

 

Proven pulmonary dimorphic (endemic) fungus - one or both of the following:

(1) positive culture from sputum, BAL or lung biopsy AND comparable signs and symptoms

(2) microscopic identification in specimen

 

Proven extrapulmonary dimorphic (endemic) fungus extrapulmonary - one or both of the following:

(1) positive culture from site affected AND comparable signs and symptoms

(2) microscopic identification in specimen

 

Proven disseminated dimorphic (endemic) fungus - one or both of the following:

(1) positive blood culture

(2) antigen demonstrated in serum or urine

 

Probable invasive fungal infections – not proven and all of the following:

(1) >= 1 host factor

(2) >= 1 microbiological criterion

(3) one of the following:

(3a) >= 1 major clinical criterion

(3b) >= 2 minor clinical criterion

 

Probable disseminated candidiasis – not proven and all of the following:

(1) >= 1 host factor

(2) characteristic lesions

 

Probable candidemia – not proven and all of the following:

(1) >= 1 host factor

(2) >= 1 microbiological criterion indicating Candidemia

 

Possible invasive fungal infection – not probable and all of the following:

(1) >= 1 host factor

(2) one of the following:

(2a) >= 1 microbiological criterion

(2b) >= 1 major clinical criterion

(2c) >= 2 minor clinical criterion

 

where:

• The clinical criteria are for lower respiratory tract, sinonasal, CNS or disseminated infections.

 


To read more or access our algorithms and calculators, please log in or register.